Immunoconjugates

Details Immunoconjugates Immunoconjugates

2005-12-27

2005-12-27

Siew, Jeffrey (Department: 1642)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S387700

Reexamination Certificate

active

06979726

ABSTRACT:
The present invention relates to new fusion proteins which consist of a tumor-associated targeting element preferentially a monoclonal antibody or a fragment thereof recognizing a molecule which is preferentially expressed on human tumor cells such as the human epidermal growth factor receptor (EGFR), and a biologically active ligand such as a growth and/or differentiation factor. The resulting fusion protein may be used to deliver the biologically active ligand to a specific target cell or tissue. The new immunoconjugates can be used in tumor therapy.

REFERENCES:
patent: 5314995 (1994-05-01), Fell, Jr. et al.
patent: 5470571 (1995-11-01), Herlyn et al.
patent: 53795 (1990-12-01), None
patent: 0 396 387 (1990-11-01), None
patent: 0 439 095 (1991-07-01), None
patent: 0 586 002 (1994-03-01), None
patent: 91/03489 (1991-03-01), None
patent: 95/08495 (1992-05-01), None
patent: 92/15683 (1992-09-01), None
patent: 93/00917 (1993-01-01), None
patent: 95/25167 (1995-09-01), None
Morrison SL Hospital Practice Oct. 15, 1989 pp 65-80.
John Mendelsohn, Monographs (National Center Inst.) No. 15 pp. 125-131, 1992.
Adachi K et al (J. Nippon Medical School Oct. 1991, 58 (5) 537-46, abstract only.
Lappin MB et al Blood Reviews 2000;14:228-239.
Naramura et al (Immunol Lett. Dec. 1993; 39(1):91-9).
Mendelsohn, John, “Growth Factor Receptors as Targets for Antitumor Therapy with Monoclonal Antibodies”,Monoclonal Antibody Therapy Prog. Allergy, Basel, Karger, 1988, vol. 45, pp. 147-160.
Chemical Abstracts, vol. 120, No. 21, May 23, 1994.
U.P. Shinde et al., “Protein memory through altered folding mediated by intramolecular chaperones”,Nature, vol. 389, pp. 520.522, Oct. 1987.
Philip J. Bassford et al., “Use of Gene Fusion to Study Secretion of Maltose-Binding Protein intoEscherichia coliPeriplasm”,J. of Bacteriology, 139(1): Jul. 19-31, 1979.
DIALOG Abstract, Winther et al., “Propetide of carboxypeptidase Y provides a chaperone-like function as well as inhibition of the enzymatic activity”,Proc. Natl. Acad. Sci. USA, 88(20):9330-4, Oct. 1991.

Affiliated with

Also associated with

Rating

Immunoconjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunoconjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoconjugates will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3493346